Neurodegenerative and CNS Disorders

At Ichor Research, our specialty has always been Alzheimer's disease and related dementias. With experience running studies from prodromal Alzheimer's through end-of-life diagnostic studies, our dedicated neuro team can support a wide variety of disease modifying and symptomatic studies.

GAP-NET Partner

Clinical Ratings

With 4 experienced clinical raters, our site has experience with the psychometric assessments associated with both disease modifying and symptomatic studies (agitation and psychosis) in order to ensure reliable and consistent study data.

MRI & PET

With multiple contracted local vendors, we can conduct both 1.5 and 3t MRIs. Our team is experienced in utilizing and conducting both amyloid and tau biomarker scans for eligibility and ongoing procedures.

Community Partnerships

Ichor has a unique partnership with the largest senior care provider in CNY. With the ability to bring clinical trials directly to families and residents in long-term care, our site is breaking the barriers in access to otherwise underserved patients. See more here.

IRB approved Prescreening

With multiple prescreening consent options, we have the ability to complete in person and remote prescreening procedures which can include memory testing, medical history and medical record review, and even behavioral observations.

Our Study Experience

Therapeutic Indications:

Prodromal Alzheimer's Disease
Mild Cognitive Impairment
Early (Mild), Moderate, and Severe Alzheimer's Disease
Mood and Behavioral: Psychosis and Agitation
Substance Use Disorders
Validation of Biomarkers (including investigational radiopharmaceutical and autopsy studies)

If your team would like to learn more about our ability to support your upcoming study, please complete the form below.